首页> 外文期刊>Vaccine >Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine
【24h】

Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine

机译:人类自然感染后T淋巴细胞识别的土拉弗朗西斯菌Schu4抗原的多样性:鉴定包含在合理设计的Tularemia疫苗中的候选表位

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The T lymphocyte antigens, which may have a role in protection against tularemia, were predicted by immunoinformatics analysis of Francisella tularensis Schu4. Twenty-seven class II putative promiscuous epitopes and 125 putative class I supertype epitopes were chosen for synthesis; peptides were tested in vitro for their ability to bind HLA and to induce immune responses from PBMCs of 23 previously infected subjects. While the immune responses of individual subjects showed heterogeneity, 95% of the subjects responded strongly to a pool of 27 promiscuous peptides; 25%, 33%, and 44% of subjects responded to pools of 25 A2, A24, and B7 peptides, respectively. These data can aid in the development of novel epitope-based and subunit tularemia vaccines.
机译:T淋巴细胞抗原可能对图拉弗朗西斯菌有保护作用,通过弗朗西斯菌Tularensis Schu4的免疫信息学分析预测。选择了27个II类推定的混杂表位和125个I类超型表位进行合成。在体外测试了这些肽结合HLA并诱导23名先前感染受试者的PBMC诱导免疫应答的能力。尽管个别受试者的免疫反应显示出异质性,但95%的受试者对27种混杂肽强烈反应; 25%,33%和44%的受试者分别对25种A2,A24和B7肽库有反应。这些数据可以帮助开发新型的基于表位和亚单位tularemia疫苗。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号